Skip to main content

F15.20 ICD-10-CM Code: Other stimulant dependence, uncomplicated

Billing Status: YES. This is a valid, specific, and billable ICD-10-CM reference.

Coding at a Glance

Inpatient Payment Groups (MS-DRG)

Potential MS-DRG participation — not a DRG assignment.

MS-DRGs this diagnosis helps define, as principal or secondary, per the CMS ICD-10-CM/PCS MS-DRG Definitions Manual v44, Appendix B.

  • MS-DRG 894 — ALCOHOL, DRUG ABUSE OR DEPENDENCE, LEFT AMA (MDC 20)
  • MS-DRG 895 — ALCOHOL, DRUG ABUSE OR DEPENDENCE WITH REHABILITATION THERAPY (MDC 20)
  • MS-DRG 896 — ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITH MCC (MDC 20)
  • MS-DRG 897 — ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITHOUT MCC (MDC 20)

A diagnosis appearing in a group's logic does not by itself determine the DRG assigned to a stay; the grouper uses the full claim.

Risk Adjustment (CMS-HCC)

Payment categories this diagnosis maps to under CMS-HCC V28, payment year 2026.

  • HCC 137 — Drug Use Disorder, Moderate/Severe, or Drug Use with Non-Psychotic Complications (supersedes HCC 138, HCC 139)

Other models: CMS-HCC V22 HCC 55

Risk scores depend on the enrollee's full accepted diagnosis set and segment; a category mapping alone does not determine payment.

Coding instructions

Official Tabular Instructional Notes: the inclusion, exclusion and sequencing notes published for F15.20 in the official ICD-10-CM tabular list, quoted as published.

Source: CMS/CDC — ICD-10-CM Tabular ListRelease: FY2027Effective: October 1, 2026

Notes without a marker are published on F15.20 itself; “inherited from” names the category or block whose note applies here.

Includes

Conditions the official ICD-10-CM tabular list includes under this code.

  • amphetamine-related disorders
  • caffeine

Source: inherited from F15

Inclusion Terms

Alternative terms the tabular list files under this code.

  • Amphetamine type substance use disorder, moderate
  • Amphetamine type substance use disorder, severe
  • Other or unspecified stimulant use disorder, moderate
  • Other or unspecified stimulant use disorder, severe

Excludes1 — Not Coded Here

Conditions generally not reported together with this code (Excludes1) -- an error unless the two conditions are documented as unrelated to each other (ICD-10-CM Official Guidelines, Section I.A.12.a).

Source: inherited from F15.2

Excludes2 — Not Included Here

Conditions not covered by this code, but which may be reported alongside it when both are present.

Source: inherited from F15

Coder workflow for F15.20

MedCoder structured workflow — derived from this code’s own official record

Before you code F15.20

  1. “Other” (NEC) means the condition is specified in the record but no dedicated code captures it. Confirm the documented form is not one a sibling code names before settling on F15.20; if the record states no specifics at all, the unspecified sibling applies instead. “Other” codes are for documented conditions the classification gives no specific code; “unspecified” codes are for records lacking the detail (Guidelines I.A.9.a, I.A.9.b).

    See the relationships section · Guide: Other vs unspecified (NEC vs NOS) →

  2. Check the Excludes1 note: if the documentation supports a condition named there, do not simply proceed with F15.20. Excludes1 conditions are not reported together with this code unless the record shows they are unrelated (Guidelines I.A.12.a).

    See the official tabular notes

Choose the right path

  1. Does the documentation support a condition named in F15.20’s Excludes1 note?
    Yes → Do not simply proceed: review the excluded code. Both are reported only when the record shows the two conditions are unrelated.
    No → Continue.

    ReviewF15.1, F15.9

Consider F15.20. Then confirm the code is valid for the date of service in the Verify section.

Documentation check

The provider’s diagnostic statement
Codes are assigned from the provider’s documented diagnosis, not from clinical criteria, test values or a medication list (Guidelines I.A.19).
The associated condition or complication
Whether the associated condition the title names is documented; the “with” convention presumes some links, and a provider statement that the conditions are unrelated defeats it (Guidelines I.A.15).
Any detail beyond this code’s title
What the record states that a more specific sibling code would capture — or its absence, which itself supports the unspecified code.

Official instructions as workflow

  • Excludes1 — check before selecting F15.20(2 notes)

    Coding workflow: If the documentation supports a condition named in this note, do not simply proceed with F15.20: the two are not reported together. The one exception is when the record shows the two conditions are unrelated to each other.

    CompareF15.1, F15.9

    See the official tabular notes · Guidelines I.A.12.a

  • Excludes2 — not part of F15.20(1 note)

    Coding workflow: The conditions named in this note are not included in F15.20. When the record documents both, both may be reported; the note is a boundary, not a prohibition.

    CompareF14

    See the official tabular notes · Guidelines I.A.12.b

Coding decision scenarios

Pattern scenarios for this code’s structure — decision rules, not clinical cases

Documentation: Both the condition F15.20 describes and a condition named in its Excludes1 note are documented for the same encounter.

Coding question: Can both codes be reported?

Path: Review the Excludes1 note and the excluded code, and look for a provider statement on whether the two conditions are related.

Reason: Excludes1 means the two are not coded together; the exception is when the record shows the conditions are unrelated to each other (Guidelines I.A.12.a).

ReviewF15.1, F15.9

Every row is derived from this code’s own record — its title, tabular notes, 7th-character family and same-category siblings — with fixed MedCoder wording; nothing is inferred about a patient. The official notes and guideline text are in the sections each row links to, and they control.

Code Overview

Other stimulant dependence, uncomplicated is a billable ICD-10-CM diagnosis code (F15.20).

MedCoder summary Summary composed by MedCoder from this code's official ICD-10-CM record. The tabular instructional notes themselves appear verbatim below.

Indexed Clinical Terms (4)

Official source data — entries quoted as published, in the Index’s own lookup phrasing

Clinical term phrases from the official ICD-10-CM Index to Diseases and Injuries that map to this code. These are alphabetic-index entries shown as the Index writes them — lookup phrasing, not necessarily the wording of a final diagnosis.

Verify Before Coding

  • CC as a secondary diagnosis (FY2027). Can raise the stay's MS-DRG severity tier.

From the code registry, the Medicare Code Editor, and the MS-DRG Definitions Manual. Check it against a full claim in Claim Check.

Relationships & Classification

MedCoder structured relationships — computed from published CMS and AHRQ datasets

Other codes that name F15.20 or its code family, from the CMS ICD-10-CM tabular instructional notes. Tabular-note edges are stored at the code family level that carries each note.

Referenced by 4 Excludes1 notes across 2 chapters: F15.1 — Other stimulant abuse (via F15.2.-), F15.9 — Other stimulant use, unspecified (via F15.2.-), R41.3 — Other amnesia (via F15.-), R44 — Other symptoms and signs involving general sensations and perceptions (via F15.-).

These codes’ tabular lists mark this diagnosis as mutually exclusive — not reported together unless the conditions are documented as unrelated.

Referenced by 34 Excludes2 notes across 4 chapters: F02 — Dementia in other diseases classified elsewhere (via F15.-), F06 — Other mental disorders due to known physiological condition (via F15.-), F06.0 — Psychotic disorder with hallucinations due to known physiological condition (via F15.-), F06.2 — Psychotic disorder with delusions due to known physiological condition (via F15.-), F06.3 — Mood disorder due to known physiological condition (via F15.-), F06.4 — Anxiety disorder due to known physiological condition (via F15.-), F14 — Cocaine related disorders (via F15.-), F20 — Schizophrenia (via F15.-), F55 — Abuse of non-psychoactive substances (via F15.-), F63 — Impulse disorders (via F15.-), F63.1 — Pyromania (via F15.-), R78 — Findings of drugs and other substances, not normally found in blood (via F15.-), T36 — Poisoning by, adverse effect of and underdosing of systemic antibiotics (via F15.-), T36-T39 — Antibiotics & Anti-infectives (T36-T39) (via F15.-), T36-T50 — Poisoning by, adverse effects of and underdosing of drugs, medicaments and biological substances (T36-T50) (via F15.-), T37 — Poisoning by, adverse effect of and underdosing of other systemic anti-infectives and antiparasitics (via F15.-), T38 — Poisoning by, adverse effect of and underdosing of hormones and their synthetic substitutes and antagonists, not elsewhere classified (via F15.-), T39 — Poisoning by, adverse effect of and underdosing of nonopioid analgesics, antipyretics and antirheumatics (via F15.-), T40 — Poisoning by, adverse effect of and underdosing of narcotics and psychodysleptics [hallucinogens] (via F15.-), T40-T41 — Analgesics & Antipyretics (T40-T41) (via F15.-), +14 more.

These codes’ tabular lists name this diagnosis as distinct — both may be reported when both are documented.

Referenced by 2 Use Additional Code instructions across 2 chapters: O99.32 — Drug use complicating pregnancy, childbirth, and the puerperium (via F15.-), Z71.5 — Drug abuse counseling and surveillance (via F15.-).

These codes instruct coders to additionally report this code when it applies.

MS-DRG Grouper Relationships (FY2027)

Potential MS-DRG participation — not a DRG assignment.

FY2027 MS-DRG: CC — Complication or Comorbidity. Reported as a secondary diagnosis, this code raises the stay's MS-DRG severity tier — except when the principal diagnosis is one of 1 clinically related codes on its CMS exclusion list.

Named in the grouper logic of 4 MS-DRGs: DRG 894 (MDC 20), DRG 895 (MDC 20), DRG 896 (MDC 20), DRG 897 (MDC 20).

From the CMS MS-DRG Definitions Manual (Appendices B and C). Actual DRG assignment depends on the complete claim.

Clinical classification (AHRQ CCSR):MBD021 — Stimulant-related disorders (default).

Clinical Classifications Software Refined (CCSR) for ICD-10-CM Diagnoses. Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality.

Related Codes

Same CMS-HCC risk category (V28)

CMS maps these diagnoses to the same Hierarchical Condition Category (Drug Use Disorder, Moderate/Severe, or Drug Use with Non-Psychotic Complications) for risk-adjusted payment.

F15.121 — Other stimulant abuse with intoxication delirium, F15.122 — Other stimulant abuse with intoxication with perceptual disturbance, F15.129 — Other stimulant abuse with intoxication, unspecified, F15.13 — Other stimulant abuse with withdrawal, F15.14 — Other stimulant abuse with stimulant-induced mood disorder, F15.180 — Other stimulant abuse with stimulant-induced anxiety disorder, F15.181 — Other stimulant abuse with stimulant-induced sexual dysfunction, F15.182 — Other stimulant abuse with stimulant-induced sleep disorder, F15.188 — Other stimulant abuse with other stimulant-induced disorder, F15.19 — Other stimulant abuse with unspecified stimulant-induced disorder, F15.21 — Other stimulant dependence, in remission, F15.220 — Other stimulant dependence with intoxication, uncomplicated, F15.221 — Other stimulant dependence with intoxication delirium, F15.222 — Other stimulant dependence with intoxication with perceptual disturbance, F15.229 — Other stimulant dependence with intoxication, unspecified, F15.23 — Other stimulant dependence with withdrawal, F15.24 — Other stimulant dependence with stimulant-induced mood disorder, F15.280 — Other stimulant dependence with stimulant-induced anxiety disorder, F15.281 — Other stimulant dependence with stimulant-induced sexual dysfunction, F15.282 — Other stimulant dependence with stimulant-induced sleep disorder, +287 more

Related risk categories

These categories interact through CMS's HCC hierarchy — one can suppress the other's risk-adjustment weight when both are present on a claim.

Drug Use with Psychotic Complications, Alcohol Use with Psychotic Complications, Drug Use Disorder, Mild, Uncomplicated, Except Cannabis, Alcohol Use Disorder, Moderate/Severe, or Alcohol Use with Specified Non-Psychotic Complications

Same clinical category (CCSR)

AHRQ's Clinical Classifications Software groups these diagnoses under the same clinical category (Stimulant-related disorders).

F15.13 — Other stimulant abuse with withdrawal, F15.14 — Other stimulant abuse with stimulant-induced mood disorder, F15.150 — Other stimulant abuse with stimulant-induced psychotic disorder with delusions, F15.151 — Other stimulant abuse with stimulant-induced psychotic disorder with hallucinations, F15.159 — Other stimulant abuse with stimulant-induced psychotic disorder, unspecified, F15.180 — Other stimulant abuse with stimulant-induced anxiety disorder, F15.181 — Other stimulant abuse with stimulant-induced sexual dysfunction, F15.182 — Other stimulant abuse with stimulant-induced sleep disorder, F15.188 — Other stimulant abuse with other stimulant-induced disorder, F15.19 — Other stimulant abuse with unspecified stimulant-induced disorder, F15.220 — Other stimulant dependence with intoxication, uncomplicated, F15.221 — Other stimulant dependence with intoxication delirium, F15.222 — Other stimulant dependence with intoxication with perceptual disturbance, F15.229 — Other stimulant dependence with intoxication, unspecified, F15.23 — Other stimulant dependence with withdrawal, F15.24 — Other stimulant dependence with stimulant-induced mood disorder, F15.250 — Other stimulant dependence with stimulant-induced psychotic disorder with delusions, F15.251 — Other stimulant dependence with stimulant-induced psychotic disorder with hallucinations, F15.259 — Other stimulant dependence with stimulant-induced psychotic disorder, unspecified, F15.280 — Other stimulant dependence with stimulant-induced anxiety disorder, +108 more

Same Index main term, other category

The ICD-10-CM Index to Diseases and Injuries files this code under the main term “Dependence”; these codes share that main term but sit in a different category of the Tabular List.

F14.23 — Cocaine dependence with withdrawal (drug NEC, cocaine, with, withdrawal), F14.24 — Cocaine dependence with cocaine-induced mood disorder (drug NEC, cocaine, with, mood disorder), F14.250 — Cocaine dependence with cocaine-induced psychotic disorder with delusions (drug NEC, cocaine, with, psychosis, delusions), F14.251 — Cocaine dependence with cocaine-induced psychotic disorder with hallucinations (drug NEC, cocaine, with, psychosis, hallucinations), F14.259 — Cocaine dependence with cocaine-induced psychotic disorder, unspecified (drug NEC, cocaine, with, psychosis), F14.280 — Cocaine dependence with cocaine-induced anxiety disorder (drug NEC, cocaine, with, anxiety disorder), F14.281 — Cocaine dependence with cocaine-induced sexual dysfunction (drug NEC, cocaine, with, sexual dysfunction), F14.282 — Cocaine dependence with cocaine-induced sleep disorder (drug NEC, cocaine, with, sleep disorder), F14.288 — Cocaine dependence with other cocaine-induced disorder (drug NEC, cocaine, with, other specified disorder), F14.29 — Cocaine dependence with unspecified cocaine-induced disorder (drug NEC, cocaine, with, unspecified disorder), F16.20 — Hallucinogen dependence, uncomplicated (drug NEC, hallucinogen), F16.21 — Hallucinogen dependence, in remission (drug NEC, hallucinogen, in remission), F16.220 — Hallucinogen dependence with intoxication, uncomplicated (drug NEC, hallucinogen, with, intoxication, uncomplicated), F16.221 — Hallucinogen dependence with intoxication with delirium (drug NEC, hallucinogen, with, intoxication, with delirium), F16.229 — Hallucinogen dependence with intoxication, unspecified (drug NEC, hallucinogen, with, intoxication), F16.24 — Hallucinogen dependence with hallucinogen-induced mood disorder (drug NEC, hallucinogen, with, mood disorder), F16.250 — Hallucinogen dependence with hallucinogen-induced psychotic disorder with delusions (drug NEC, hallucinogen, with, psychosis, delusions), F16.251 — Hallucinogen dependence with hallucinogen-induced psychotic disorder with hallucinations (drug NEC, hallucinogen, with, psychosis, hallucinations), F16.259 — Hallucinogen dependence with hallucinogen-induced psychotic disorder, unspecified (drug NEC, hallucinogen, with, psychosis), F16.280 — Hallucinogen dependence with hallucinogen-induced anxiety disorder (drug NEC, hallucinogen, with, anxiety disorder), +149 more

Lab tests where this diagnosis supports Medicare coverage (NCD)

Medicare's National Coverage Determination (NCD) program lists this diagnosis as medical justification for these lab tests.

Gamma-glutamyl Transferase (GGT) Test

Contextual Map

Every relationship of F15.20 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.

Run F15.20 with these 14 related codes in Claim Check

Hierarchy

Referenced by Excludes1 notes

Referenced by Excludes2 notes (34)

Referenced by Use Additional Code instructions

Clinical classification (CCSR)

Risk adjustment (CMS-HCC)

  • HCC 137 — Drug Use Disorder, Moderate/Severe, or Drug Use with Non-Psychotic Complications [CMS-HCC]: “Drug Use Disorder, Moderate/Severe, or Drug Use with Non-Psychotic Complications — supersedes HCC 138 (Drug Use Disorder, Mild, Uncomplicated, Except Cannabis), HCC 139 (Alcohol Use Disorder, Moderate/Severe, or Alcohol Use with Specified Non-Psychotic Complications)”— CMS-HCC V28 · 2026

MS-DRG Grouper

MDC crossing

  • MDC 20 — Alcohol or Drug Use or Induced Organic Mental Disorders[MDC crossing]: “Alcohol or Drug Use or Induced Organic Mental Disorders — the grouper's crossing between diagnoses and procedures: a principal diagnosis sets the MDC, and same-MDC procedures move the stay to its surgical DRGs. 35 same-MDC procedures group here; browse them on the MDC page.”— CMS MS-DRG Definitions Manual · FY2027

Index entries

  • Dependence (on) (syndrome), drug NEC, stimulant NEC[Index term]— CMS ICD-10-CM Index to Diseases and Injuries · icd10cm-fy2026
  • Disorder (of), amphetamine-type substance use, moderate[Index term]— CMS ICD-10-CM Index to Diseases and Injuries · icd10cm-fy2026
  • Disorder (of), amphetamine-type substance use, severe[Index term]— CMS ICD-10-CM Index to Diseases and Injuries · icd10cm-fy2026
  • Disorder (of), stimulant use (other) (unspecified), moderate or severe[Index term]— CMS ICD-10-CM Index to Diseases and Injuries · icd10cm-fy2026

Nearest codes (40)

Change history

  • FY2016 — In the code set at ICD-10-CM adoption [Change history]— CMS release files (code change ledger) · icd10cm-fy2016

Sources for this page

Codes, titles, notes, index terms and mappings on this page are transcribed from the datasets below. Relationships MedCoder computed and text MedCoder wrote are labelled where they appear.

Code, title, tabular notes and index terms Official source data
CMS/CDC ICD-10-CM FY2027 tabular list, index and tables, effective October 1, 2026 Release, file and checksum · Publisher’s page
Claim edits Official source data
CMS Definitions of Medicare Code Edits — v44.0 (October 2026) Release, file and checksum · Publisher’s page
Inpatient payment groups Official source data
CMS MS-DRG Definitions Manual (incl. Appendix B diagnosis index, Appendix C CC/MCC list, Appendix E procedure index) and IPPS Final Rule tables — v44 Release, file and checksum · Publisher’s page
Risk adjustment Official source data
2026 Mid-Year Final ICD-10 Mappings + Model Software (cms.gov/files/zip/2026-midyear-final-icd-10-mappings.zip, 2026-midyear-final-model-software.zip) — CMS-HCC V28, PY2026 mid-year final release Release, file and checksum · Publisher’s page
Change history and date-of-service validity Official source data
CMS ICD-10-CM release addenda, ingested release by release into the change ledger Release, file and checksum · Publisher’s page
Comparisons, relationships and the contextual map MedCoder structured relationship
Computed by MedCoder from the tabular notes and tables above; every derived relationship is marked as derived where it appears
Summary and FAQ answers MedCoder explanation
Written by MedCoder to explain the sources above: drafted with AI assistance, checked by a person against the release files, and labelled as MedCoder text where it appears. Not official text.

Labels on this page: Official source data · MedCoder structured relationship · MedCoder explanation. How to read the labels · All data sources and release dates

Cite this page

Reference this page in a research guide, syllabus or article. The release is included because code content changes each year.

MedCoder.ai. "F15.20 — Other stimulant dependence, uncomplicated." ICD-10-CM FY2027. https://medcoder.ai/icd10/code/f15.20-other-stimulant-dependence-uncomplicated

Change history

  • FY2016 — October 1, 2015
    In the code set at ICD-10-CM adoption
    Other stimulant dependence, uncomplicated

No changes since FY2016 — additions, deletions, description changes and billable-status changes are tracked through FY2027, and none are recorded for this code. Note changes are tracked from FY2027 only.

Nearest Codes in This Family

Official ICD-10-CM classifications closest to F15.20 in its code family, with their registry titles.

View all codes in the F15 family